COMBIVENT side effects and interactions. Learn about medical symptoms and prescription drugs interactions, reported by thousands of patients.

Bookmark this page - Make Home Page - Add to del.icio.us

Find Drug Reports

Frequently Reported Drugs

Actonel
  Actos
  Advil
  Allegra
  Ambien
  Avandia

Baclofen
Boniva

  Celebrex
  Celexa
  Combivent
  Cymbalta

Depakote
Diovan

Effexor
Evista

  Femara
  Flomax
  Fosamax

  Gabapentin
  Glucophage
  Glyburide

Hydralazine

Insulin
Imitrex

  Levitra
  Lexapro
  Lipitor
  Lisinopril
  Lyrica

  Metoprolol
  Mobic
  Motrin

  Naproxen
  Neurontin
  Nexium
  Norvasc

Oxycodone

  Paxil
  Percocet
  Prednisone
  Premarin
  Propecia
  Protonix
  Prozac

Renova

  Seroquel
  Singulair
  Tamiflu
  Topamax
  Tramadol
  Ultram
  Ultracet
  Valtrex
  Valium
  Viagra
  Vicodin
  Vioxx
  Wellbutrin
  Xanax
  Xenical
  Zoloft
  Zyrtec

COMBIVENT
Total reports: 70
Reported deaths: 10 Reported hospitalizations: 45
Learn about COMBIVENT serious adverse events reported to Food and Drug Administration (FDA). ……………………………………………………………………………………………… COMBIVENT FDA safety alerts: No
Read More Here.

Commonly reported COMBIVENT side effects: pharmaceutical product complaint, dysgeusia, pneumonia viral, pneumonia, pneumonia aspiration, dyspnoea, throat tightness, respiratory failure, pharyngeal oedema, parosmia, dyspnoea exertional.

COMBIVENT Interactions with: Hydrochlorothiazide . Lasix . Oxygen . Flovent . Alprazolam . Proventil . Xanax . Isosorbide . Synthroid . Advair diskus . Xopenex . Amitriptyline . Aspirin . Naprosyn . Probenecid . Norvasc . Lovastatin . Diovan . Serevent . Prednisone . Toprol . Vioxx . Lisinopril . Nexium . Topamax . Trazodone . Beclomethasone dipropionate . Lexapro . Cardizem la . Claritin
…………………………………………………………………………………….

Showing 1-50 of 70 Next >

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Dec 01, 2005. Female patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dyspnoea. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2005. Female patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dyspnoea. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Nov 08, 2005. Male patient was diagnosed with emphysema and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, constipation, coronary artery occlusion, dyspnoea. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Physician from on Jan 27, 2006. Female patient was diagnosed with bronchitis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug exposure during pregnancy, ectopic pregnancy. COMBIVENT dosage: STRENGTH: 0.02+0.120 MG. Patient recovered.

Physician from reported COMBIVENT problem on Feb 17, 2006. Male patient, weighting 27.56 lb, was diagnosed with asthma and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dyskinesia, hypothermia. COMBIVENT dosage: unknown. During the same period patient was treated with SINGULAIR, RINELON. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Physician from on Feb 17, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. COMBIVENT dosage: unknown. During the same period patient was treated with SIOPEL CREAM, SALBUTAMOL, QUININE SULPHATE, FRUSEMIDE, GLICLAZIDE, BECLOMETHASONE DIPROPIONATE, DICLOFENAC, BECLOMETHASONE DIPROPIONATE. Patient died on 10/04/2000.

Physician from UNITED STATES reported COMBIVENT problem on Sept 08, 2005. Male patient, 77 years of age, weighting 222.7 lb, was diagnosed with osteoarthritis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, arthropathy, basal cell carcinoma, cardiac failure congestive, chronic obstructive pulmonary disease, drug hypersensitivity, gastrooesophageal reflux disease, glaucoma, hypertension. COMBIVENT dosage: unknown. During the same period patient was treated with TIMOPTIC, XALATAN, TIAZAC, LOTENSIN, TOPROL, VIOXX, LIPITOR, LESCOL. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Pharmacist from UNITED STATES on Mar 03, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, sleep disorder and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dysgeusia, osteoporosis. COMBIVENT dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Dec 12, 2005. Female patient was diagnosed with asthma, cough and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: burning sensation, chapped lips, cheilitis, dysgeusia, loss of consciousness. COMBIVENT dosage: unknown. During the same period patient was treated with LEXAPRO, CARDIZEM LA, CLARITIN, AMBIEN, PSEUDOFED PD. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Physician from on Mar 16, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. COMBIVENT dosage: unknown. During the same period patient was treated with ASPIRIN, VITAMIN B CAP, SERETIDE. Patient died on 11/21/2005.

Physician from UNITED KINGDOM reported COMBIVENT problem on Mar 16, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. COMBIVENT dosage: unknown. During the same period patient was treated with ASPIRIN, VITAMIN B CAP, SERETIDE. Patient died on 11/21/2005.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Male patient was diagnosed with asthma, gout, cardiac disorder, diuretic therapy and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: candidiasis, pneumonia, pneumonia viral, staphylococcal infection. COMBIVENT dosage: unknown. During the same period patient was treated with NAPROSYN, PROBENECID, NORVASC, LOVASTATIN, DIOVAN, HYDROCHLOROTHIAZIDE, FLOVENT, SEREVENT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Mar 27, 2006. Female patient, 79 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: bronchitis acute, pleurisy, pneumonia. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2005. Female patient was diagnosed with asthma, cough and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: burning sensation, chapped lips, cheilitis, dysgeusia, loss of consciousness. COMBIVENT dosage: unknown. During the same period patient was treated with LEXAPRO, CARDIZEM LA, CLARITIN, AMBIEN, PSEUDOFED PD. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Sept 28, 2005. Male patient, 64 years of age, weighting 271.2 lb, was diagnosed with arthritis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, carpal tunnel syndrome, cerebrovascular accident, coronary artery disease, dementia alzheimer's type, emphysema, hypertensive heart disease, lung disorder. COMBIVENT dosage: unknown. During the same period patient was treated with LASIX, ISOSORBIDE, LANOXIN, LISINOPRIL, PROTONIX, AVANDIA, FLOMAX, VIOXX. Patient was hospitalized. Patient died on 01/20/2004.

COMBIVENT problem was reported by a Pharmacist from UNITED STATES on Apr 04, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug ineffective, dyspnoea, lung infection. COMBIVENT dosage: unknown. Patient died on 01/01/2006.

Pharmacist from UNITED STATES reported COMBIVENT problem on Mar 03, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, sleep disorder and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dysgeusia, osteoporosis, pharmaceutical product complaint, poor quality drug administered. COMBIVENT dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Physician from CHILE on Apr 12, 2006. Female patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: obstructive airways disorder. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 14, 2006. Female patient was diagnosed with lung disorder, diabetes mellitus and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: cough, fall. COMBIVENT dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Male patient was diagnosed with asthma, gout, cardiac disorder, diuretic therapy and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: candidiasis, pneumonia, pneumonia viral, staphylococcal infection. COMBIVENT dosage: unknown. During the same period patient was treated with NAPROSYN, PROBENECID, NORVASC, LOVASTATIN, DIOVAN, HYDROCHLOROTHIAZIDE, FLOVENT, SEREVENT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COMBIVENT problem on Mar 03, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, sleep disorder and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dysgeusia, osteoporosis, pharmaceutical product complaint, spinal operation. COMBIVENT dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Pharmacist from on Jan 23, 2003. Female patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea, failure of implant, oedema. COMBIVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration, throat cancer. COMBIVENT dosage: unknown. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Male patient was diagnosed with asthma, gout, cardiac disorder, diuretic therapy and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: candidiasis, pharmaceutical product complaint, pneumonia, pneumonia viral, staphylococcal infection. COMBIVENT dosage: unknown. During the same period patient was treated with NAPROSYN, PROBENECID, NORVASC, LOVASTATIN, DIOVAN, HYDROCHLOROTHIAZIDE, FLOVENT, SEREVENT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COMBIVENT problem on Mar 03, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, sleep disorder and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dysgeusia, osteoporosis. COMBIVENT dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Physician from UNITED STATES on Jan 26, 2006. Male patient, 49 years of age, weighting 319.7 lb, was diagnosed with osteoarthritis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: adrenal adenoma, angina pectoris, blood cholesterol increased, cardiac disorder, coronary artery disease, depression, diarrhoea, dyspnoea, gastroenteritis. COMBIVENT dosage: unknown. During the same period patient was treated with FLOVENT, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VANCENASE, PREDNISONE, VANCERIL, VIOXX, ALLEGRA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Apr 04, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug ineffective, dyspnoea, lung infection. COMBIVENT dosage: unknown. Patient died on 01/01/2006.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Female patient was diagnosed with lung disorder, diabetes mellitus and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: cough, fall, pharmaceutical product complaint. COMBIVENT dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 21, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, impaired work ability. COMBIVENT dosage: unknown. Patient recovered.

COMBIVENT problem was reported by a Physician from on Jan 23, 2006. Female patient was diagnosed with bronchitis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug exposure during pregnancy, ectopic pregnancy. COMBIVENT dosage: STRENGTH: 0.02+0.120 MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on May 18, 2006. Female patient, 34 years of age, was diagnosed with dyspnoea, hypothyroidism, migraine prophylaxis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea exacerbated. COMBIVENT dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, PREDNISONE, XOPENEX, NEXIUM, SYNTHROID, TOPAMAX. Patient recovered.

COMBIVENT problem was reported by a Physician from UNITED STATES on Apr 04, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug ineffective, dyspnoea, lung infection. COMBIVENT dosage: unknown. Patient died on 01/01/2006.

Pharmacist from UNITED STATES reported COMBIVENT problem on May 24, 2006. Female patient, 85 years of age, was diagnosed with asthma, chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug effect decreased, dysgeusia, pharmaceutical product complaint. COMBIVENT dosage: unknown. Patient recovered.

COMBIVENT problem was reported by a Physician from UNITED STATES on Apr 04, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: drug ineffective, dyspnoea, gastrointestinal haemorrhage, lung infection, pharmaceutical product complaint. COMBIVENT dosage: unknown. Patient died on 01/01/2006.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Female patient, 57 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: parosmia, pharmaceutical product complaint, pharyngeal oedema, pneumonia, respiratory failure, throat tightness. COMBIVENT dosage: unknown. During the same period patient was treated with ALPRAZOLAM, ISOSORBIDE, HYDROCHLOROTHIAZIDE, PROVENTIL, LASIX, XANAX, OXYGEN. Patient was hospitalized and became disabled. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from on May 26, 2006. Male patient, 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: breath sounds abnormal, condition aggravated, drug ineffective, dyspnoea exertional, forced expiratory volume increased, oedema peripheral, respiratory rate increased. COMBIVENT dosage: unknown. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Female patient, 57 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: parosmia, pharyngeal oedema, pneumonia, respiratory failure, throat tightness. COMBIVENT dosage: unknown. During the same period patient was treated with ALPRAZOLAM, ISOSORBIDE, HYDROCHLOROTHIAZIDE, PROVENTIL, LASIX, XANAX, OXYGEN. Patient was hospitalized and became disabled. Patient recovered.

COMBIVENT problem was reported by a Physician from UNITED STATES on Apr 28, 2006. Female patient, 57 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: parosmia, pharmaceutical product complaint, pharyngeal oedema, pneumonia, respiratory failure, throat tightness. COMBIVENT dosage: unknown. During the same period patient was treated with ALPRAZOLAM, ISOSORBIDE, HYDROCHLOROTHIAZIDE, PROVENTIL, LASIX, XANAX, OXYGEN. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration, throat cancer. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Pharmacist from UNITED STATES on June 06, 2006. Male patient, 65 years of age, weighting 187.4 lb, was diagnosed with mitral valve replacement, tricuspid valve replacement and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, bacterial infection, device related infection, pharmaceutical product complaint, pneumonia. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Female patient, 57 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: parosmia, pharyngeal oedema, pneumonia, respiratory failure, throat tightness. COMBIVENT dosage: unknown. During the same period patient was treated with ALPRAZOLAM, ISOSORBIDE, HYDROCHLOROTHIAZIDE, PROVENTIL, LASIX, XANAX, OXYGEN. Patient was hospitalized and became disabled. Patient recovered.

COMBIVENT problem was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, 34 years of age, was diagnosed with dyspnoea, asthma, gastrooesophageal reflux disease, hypothyroidism, migraine prophylaxis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea exacerbated. COMBIVENT dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, PREDNISONE, XOPENEX, NEXIUM, SYNTHROID, TOPAMAX, XOPENEX HFA. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Female patient, 57 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: parosmia, pharyngeal oedema, pneumonia, respiratory failure, throat tightness. COMBIVENT dosage: unknown. During the same period patient was treated with ALPRAZOLAM, ISOSORBIDE, HYDROCHLOROTHIAZIDE, PROVENTIL, LASIX, XANAX, OXYGEN. Patient was hospitalized and became disabled. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration, throat cancer. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 21, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, impaired work ability. COMBIVENT dosage: unknown. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2006. Female patient was diagnosed with asthma, breast cancer and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: breast cancer, epistaxis. COMBIVENT dosage: unknown. During the same period patient was treated with ARIMEDEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on Apr 28, 2006. Male patient was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: pharmaceutical product complaint, pneumonia aspiration, throat cancer. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from CANADA on Apr 25, 2006. Female patient, 55 years of age, weighting 160.0 lb, was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: cognitive deterioration, disability, fall, myocardial infarction, subdural haematoma, surgery, weight increased. COMBIVENT dosage: unknown. During the same period patient was treated with VENTOLIN, FLOVENT, VALPROIC ACID, CLOPIXOL, SYNTHROID, PROCYCLIDINE HYDROCHLORIDE, OXYBUTYNIN, MOBIC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported COMBIVENT problem on Jan 25, 2006. Female patient, 62 years of age, weighting 160.3 lb, was diagnosed with dyspnoea and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: pneumonia. COMBIVENT dosage: unknown. During the same period patient was treated with THALIDOMIDE, LYRICA, CELEBREX, CYTOXAN, VELCADE, DARVON. Patient was hospitalized. Patient recovered.

COMBIVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2006. Female patient, 79 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: bronchitis acute, pleurisy, pneumonia. COMBIVENT dosage: unknown. Patient was hospitalized. Patient recovered.

…………………………………………………………………………………….

Showing 1-50 of 70 Next >